Endothelin-1 and endothelin-3 modulate dopaminergic neurons through different mechanisms.
K Horie, A Morita, H Yokogoshi
Index: Life Sci. 57(8) , 735-41, (1995)
Full Text: HTML
Abstract
Novel vasoconstrictor peptides, endothelin-1 (ET-1) and endothelin-3 (ET-3), are also known as neuropeptides or neuromodulators. When either ET-1 or ET-3 was administered to the rat striatum via a microinjection needle, the dopamine release from the striatum dose-dependently increased. Pretreatment with a glutamate receptor blocker, glutamate diethyl ester hydrochloride, inhibited the dopamine release induced by ET-3, whereas it further enhanced the dopamine release by ET-1. This suggests that ET-1 directly induces the dopamine release, whereas the action of ET-3 is mediated by glutamate receptors. We postulate that this difference may result from the different distributions of endothelin receptors: ETA receptors may be present on the dopaminergic neurons, but ETB receptors on the glutamatergic neurons.
Related Compounds
Related Articles:
2002-11-08
[Life Sci. 71(25) , 2961-72, (2002)]
1997-12-11
[J. Auton. Nerv. Syst. 67(3) , 145-55, (1997)]
2008-06-01
[Biochim. Biophys. Acta 1780(6) , 881-91, (2008)]
2001-11-01
[Am. J. Physiol. Regul. Integr. Comp. Physiol. 281(5) , R1665-74, (2001)]
2008-01-01
[Eur. J. Med. Chem. 43(1) , 189-203, (2008)]